| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,323 |
16,737 |
$1.79M |
| 90834 |
Psychotherapy, 45 minutes with patient |
5,220 |
3,703 |
$1.09M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,801 |
4,660 |
$622K |
| 90832 |
Psychotherapy, 30 minutes with patient |
3,302 |
2,503 |
$571K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,908 |
4,733 |
$553K |
| 36415 |
Collection of venous blood by venipuncture |
7,551 |
6,645 |
$475K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,619 |
3,437 |
$426K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,527 |
2,436 |
$412K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,812 |
1,604 |
$392K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,054 |
1,898 |
$258K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
215 |
215 |
$208K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,863 |
1,733 |
$178K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,296 |
1,170 |
$165K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,025 |
1,010 |
$162K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,317 |
1,168 |
$147K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,033 |
356 |
$146K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,508 |
2,188 |
$146K |
| 80053 |
Comprehensive metabolic panel |
6,722 |
6,144 |
$136K |
| 90791 |
Psychiatric diagnostic evaluation |
678 |
623 |
$134K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
794 |
737 |
$133K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
865 |
841 |
$111K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,513 |
529 |
$105K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
363 |
350 |
$104K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,604 |
1,469 |
$74K |
| 92551 |
|
661 |
550 |
$72K |
| 70450 |
Computed tomography, head or brain; without contrast material |
232 |
225 |
$69K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,410 |
1,385 |
$68K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,906 |
1,843 |
$66K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
190 |
183 |
$58K |
| 90837 |
Psychotherapy, 53 minutes with patient |
269 |
251 |
$48K |
| 81025 |
|
877 |
854 |
$45K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
859 |
850 |
$37K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
348 |
347 |
$36K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
262 |
262 |
$31K |
| 90686 |
|
1,241 |
1,076 |
$30K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
334 |
196 |
$29K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
110 |
106 |
$24K |
| 96160 |
|
430 |
429 |
$23K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
679 |
678 |
$22K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,218 |
1,135 |
$21K |
| 99000 |
|
718 |
705 |
$20K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
579 |
561 |
$19K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
137 |
134 |
$19K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
557 |
539 |
$19K |
| 80061 |
Lipid panel |
2,196 |
2,177 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,991 |
2,936 |
$17K |
| 99173 |
|
324 |
323 |
$17K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
855 |
845 |
$17K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
131 |
128 |
$15K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,211 |
1,853 |
$15K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
51 |
51 |
$13K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
55 |
54 |
$13K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,901 |
1,882 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,101 |
816 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
77 |
77 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
882 |
865 |
$8K |
| 90670 |
|
402 |
401 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
177 |
119 |
$8K |
| 84439 |
|
1,234 |
1,216 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,225 |
5,667 |
$8K |
| 83880 |
|
239 |
193 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,157 |
1,971 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
59 |
58 |
$6K |
| 88142 |
|
214 |
213 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
54 |
54 |
$6K |
| 90656 |
|
54 |
54 |
$5K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,300 |
1,288 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
858 |
844 |
$5K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
13 |
13 |
$4K |
| 97161 |
|
44 |
44 |
$4K |
| 99402 |
|
77 |
77 |
$4K |
| 85027 |
|
1,421 |
1,361 |
$3K |
| 90633 |
|
130 |
130 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
1,156 |
1,120 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
199 |
185 |
$3K |
| 90647 |
|
231 |
230 |
$3K |
| 90723 |
|
225 |
225 |
$3K |
| 90734 |
|
60 |
60 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
26 |
25 |
$2K |
| 82607 |
|
277 |
274 |
$2K |
| 81015 |
|
2,898 |
2,675 |
$2K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
15 |
15 |
$2K |
| 96367 |
|
17 |
15 |
$2K |
| 11056 |
|
50 |
27 |
$2K |
| 86141 |
|
320 |
309 |
$2K |
| 99442 |
|
27 |
25 |
$1K |
| 87486 |
|
52 |
52 |
$1K |
| 96127 |
|
258 |
248 |
$1K |
| 90715 |
|
59 |
59 |
$1K |
| 81002 |
|
1,020 |
989 |
$1K |
| 80361 |
|
127 |
126 |
$1K |
| 87581 |
|
52 |
52 |
$1K |
| 83735 |
|
593 |
509 |
$995.71 |
| 80373 |
|
83 |
83 |
$903.63 |
| 80354 |
|
83 |
83 |
$819.99 |
| 86850 |
|
64 |
64 |
$799.11 |
| 76801 |
|
12 |
12 |
$767.15 |
| 80372 |
|
83 |
83 |
$766.98 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
213 |
211 |
$765.15 |
| 85730 |
|
461 |
431 |
$730.76 |
| 82550 |
|
315 |
308 |
$719.18 |
| 87186 |
|
288 |
271 |
$693.51 |
| 81003 |
|
1,017 |
981 |
$618.24 |
| 90681 |
|
67 |
67 |
$606.90 |
| 82728 |
|
78 |
77 |
$606.31 |
| 87102 |
|
106 |
102 |
$602.19 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
44 |
44 |
$587.68 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
73 |
71 |
$586.23 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
66 |
60 |
$562.37 |
| 83655 |
|
45 |
45 |
$558.71 |
| 80324 |
|
126 |
125 |
$552.66 |
| 80365 |
|
126 |
125 |
$540.65 |
| 80076 |
|
54 |
53 |
$494.80 |
| 87081 |
|
124 |
124 |
$494.64 |
| 99001 |
|
64 |
60 |
$483.46 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
255 |
250 |
$483.00 |
| 80346 |
|
112 |
111 |
$481.14 |
| 80348 |
|
112 |
111 |
$463.98 |
| 82746 |
|
59 |
57 |
$463.59 |
| 85610 |
|
278 |
253 |
$456.33 |
| D1206 |
Topical application of fluoride varnish |
15 |
15 |
$454.50 |
| 80358 |
|
114 |
112 |
$434.02 |
| 80359 |
|
112 |
111 |
$424.02 |
| 80353 |
|
112 |
111 |
$424.02 |
| 85651 |
|
395 |
383 |
$414.60 |
| 90671 |
|
16 |
16 |
$401.60 |
| 80321 |
|
83 |
83 |
$383.03 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
12 |
12 |
$330.68 |
| 83690 |
|
1,828 |
1,703 |
$328.16 |
| 86376 |
|
29 |
28 |
$321.77 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,207 |
1,064 |
$321.67 |
| 86901 |
|
38 |
38 |
$315.71 |
| 84481 |
|
40 |
39 |
$308.56 |
| 84703 |
|
752 |
709 |
$301.52 |
| 84702 |
|
67 |
56 |
$296.88 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
754 |
720 |
$271.55 |
| 86780 |
|
28 |
28 |
$268.29 |
| 86900 |
|
38 |
38 |
$264.62 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
966 |
888 |
$250.50 |
| 84550 |
|
64 |
48 |
$249.77 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
25 |
24 |
$235.32 |
| 93000 |
|
196 |
189 |
$226.34 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
15 |
13 |
$195.00 |
| 84484 |
|
819 |
735 |
$170.46 |
| 87340 |
|
13 |
13 |
$126.37 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
18 |
12 |
$113.22 |
| 86618 |
|
14 |
13 |
$112.98 |
| 83605 |
|
1,420 |
1,333 |
$103.93 |
| 85378 |
|
256 |
247 |
$96.57 |
| 86038 |
|
28 |
27 |
$93.60 |
| 83550 |
|
27 |
25 |
$93.23 |
| 74022 |
|
15 |
14 |
$62.40 |
| 73030 |
|
16 |
13 |
$54.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
32 |
32 |
$52.00 |
| 84436 |
|
12 |
12 |
$34.20 |
| 83540 |
|
12 |
12 |
$30.18 |
| 86308 |
|
16 |
15 |
$29.40 |
| 87040 |
|
222 |
157 |
$24.45 |
| 85018 |
|
13 |
13 |
$22.00 |
| 85014 |
|
13 |
13 |
$22.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,125 |
1,073 |
$20.06 |
| 87070 |
|
12 |
12 |
$17.81 |
| 71045 |
Radiologic examination, chest; single view |
303 |
290 |
$6.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
957 |
895 |
$5.82 |
| 80320 |
|
28 |
25 |
$5.00 |
| 87210 |
|
12 |
12 |
$3.40 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,142 |
1,105 |
$2.67 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
627 |
617 |
$1.10 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
527 |
519 |
$1.06 |
| J2704 |
Injection, propofol, 10 mg |
376 |
371 |
$0.67 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
54 |
52 |
$0.00 |
| 99070 |
|
12 |
12 |
$0.00 |
| 73630 |
|
13 |
13 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
12 |
12 |
$0.00 |
| 81449 |
|
13 |
13 |
$0.00 |